Tachycardia-induced cardiomypathy: less usual causes, less usual treatment: 3 case-reports

Czech version

Authors: B. Holek; M. Fiala; J. Chovančík; M. Branny
Authors‘ workplace: Oddělení kardiologie, Kardiocentrum, Nemocnice Podlesí a. s., Třinec, prim. MUDr. Marian Branny
Published in: Vnitř Lék 2006; 52(2): 181-185
Category: Case Report

Overview

Tachycardia-induced cardiomypathy is a potentially reversible form of left ventricular dysfunction and heart failure that is often neglected in clinical practice. Three case-reports of tachycardia-induced cardiomyopathy associated with three different tachyarrhythmias, cured by catheter ablation, are presented. All cases were characterized by specific clinical conditions. Potential consequences of inadequate clinical analysis and treatment are discussed.

Key words:
tachycardia -⁠ induced cardiomyopathy -⁠ catheter ablation

Sources

1. Chung SS, Shen WK, Luria DM et al. First evidence of premature ventricular complex-induced cardiomyopathy: a potentially reversible cause of heart failure. J Cardiovasc Electrophysiol 2000; 11 : 328-329.

2. Fiala M, Chovančík J, Heinc P et al. Léčba symptomatické intermitentní fibrilace síní katetrovou ablací v levé srdeční síni. Bezprostřední a dlouhodobé výsledky u 150 pacientů. Vnitř Lék 2005; 51 : 971-983.

3. Grimm W, Menz V, Hoffman J et al. Reversal of tachycardia induced cardiomyopathy following ablation of repetitive monomorphic right ventricular outflow tract tachycardia. Pacing Clin Electrophysiol 2000; 11 : 328-329.

4. Grogan M, Smith HC, Gersh BJ et al. Left ventricular dysfunction due o atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 69 : 1570-1573.

5. Shinbane JS, Wood MA, Jensen DN et al. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 1997; 29 : 709-715.

6. Sweeny MO, Hellkamp AS, Ellenbogen KA et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003; 107 : 2932-2937.

7. Wren C. Incessant tachycardias. Eur Heart J. 1998; 19(Suppl E): E32-6, E54-9.